Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is ...

Inari Medical has a 12 month low of $36.73 and a 12 month high of $79.69. Insider Buying and Selling at Inari Medical In other Inari Medical news, CEO Andrew Hykes sold 3,000 shares of the stock ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports.The brokerage currently has ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral. Analyst Price Forecast Suggests 14.00% Downside As of December 23 ...

Medical device maker Inari Medical (NARI) may not be a readily-recognized name, but it is about to be part of a much bigger, and probably more recognizable, name: Stryker. Stryker agreed to buy ...

In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed ...

On Tuesday, BTIG analysts downgraded Inari Medical (TASE:PMCN) Inc. (NASDAQ: NARI) stock rating from Buy to Neutral. The decision followed the recent announcement that Stryker (NYSE: SYK) has entered ...

On Tuesday, BTIG analysts downgraded Inari Medical (TASE:PMCN) Inc. (NASDAQ: NARI) stock rating from Buy to Neutral. The decision followed the recent announcement that Stryker (NYSE: SYK ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares closed today at $79.45. Discover outperforming ...

Smith Collection / Gado / Getty Images Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition by Stryker turned into reality. Stryker will ...

Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...